Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Marchetti

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Combination of glycolysis inhibition with chemotherapy results in an antitumor immune responseMarie Bénéteau, Barbara Zunino, Marie A Jacquin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabineNicolas Magné, Jean-Louis Fischel, Alain Dubreuil, et al.
The FEBS Journal|December 19, 2020
Pharmacological preconditioning protects from ischemia/reperfusion-induced apoptosis by modulating Bcl-xL expression through a ROS-dependent mechanismRomain Rozier, Rachel Paul, Blandine Madji Hounoum, et al.
Oncogenesis|September 28, 2021
The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cellsSonia Núñez-Vázquez, José Saura-Esteller, Ismael Sánchez-Vera, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2020
Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cellsFranziska Püschel, Francesca Favaro, Jaime Redondo-Pedraza, et al.
Oncoimmunology|September 1, 2022
IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune responseAdriana Martinez-Turtos, Rachel Paul, Manuel Grima-Reyes, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 27, 2010
Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migrationAnnabelle Cesaro, Patrick Brest, Véronique Hofman, et al.
Science Advances|July 20, 2022
Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expressionManuel Grima-Reyes, Ashaina Vandenberghe, Ivan Nemazanyy, et al.
Oncotarget|March 31, 2016
Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell deathAlix Dubois, Clemence Ginet, Nathan Furstoss, et al.
Nature Communications|February 27, 2026
Tumor metabolic adaptation induced by L-asparaginase reveals a vulnerability to PARP1/2 inhibitor in B-cell lymphomasAnaïs Aussel, Ivan Nemazanyy, Ashaina Vandenberghe, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Combination of glycolysis inhibition with chemotherapy results in an antitumor immune responseMarie Bénéteau, Barbara Zunino, Marie A Jacquin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabineNicolas Magné, Jean-Louis Fischel, Alain Dubreuil, et al.
The FEBS Journal|December 19, 2020
Pharmacological preconditioning protects from ischemia/reperfusion-induced apoptosis by modulating Bcl-xL expression through a ROS-dependent mechanismRomain Rozier, Rachel Paul, Blandine Madji Hounoum, et al.
Oncogenesis|September 28, 2021
The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cellsSonia Núñez-Vázquez, José Saura-Esteller, Ismael Sánchez-Vera, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2020
Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cellsFranziska Püschel, Francesca Favaro, Jaime Redondo-Pedraza, et al.
Oncoimmunology|September 1, 2022
IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune responseAdriana Martinez-Turtos, Rachel Paul, Manuel Grima-Reyes, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 27, 2010
Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migrationAnnabelle Cesaro, Patrick Brest, Véronique Hofman, et al.
Science Advances|July 20, 2022
Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expressionManuel Grima-Reyes, Ashaina Vandenberghe, Ivan Nemazanyy, et al.
Oncotarget|March 31, 2016
Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell deathAlix Dubois, Clemence Ginet, Nathan Furstoss, et al.
Nature Communications|February 27, 2026
Tumor metabolic adaptation induced by L-asparaginase reveals a vulnerability to PARP1/2 inhibitor in B-cell lymphomasAnaïs Aussel, Ivan Nemazanyy, Ashaina Vandenberghe, et al.
Pageof 5